http://www.raredr.com/conferences/ash-2016/fitusiran-hemophilia
Fitusiran and Hemophilia: Early Data Very Promising

Pushkal Garg, MD




Pushkal Garg, MD, of Alnylam Pharmaceuticals discusses the recent data on the efficacy and safety of fitusiran to treat patients with hemophilia. 
 
The data discussed was presented at the  ASH Annual Meeting & Exposition recently held in San Diego, CA.


To stay informed on the latest in rare disease news and developments, please sign up for our weekly newsletter at www.raredr.com/newsletter
Printer Printing...
$content$